0001143313-11-000082.txt : 20110816
0001143313-11-000082.hdr.sgml : 20110816
20110816140952
ACCESSION NUMBER: 0001143313-11-000082
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20110816
DATE AS OF CHANGE: 20110816
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: TIENS BIOTECH GROUP USA INC
CENTRAL INDEX KEY: 0001168556
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 752926439
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32477
BUSINESS ADDRESS:
STREET 1: NO. 6, YUANQUAN ROAD,
STREET 2: WUQING NEW-TECH INDUSTRIAL PARK
CITY: TIANJIN, P.R.
STATE: F4
ZIP: 301700
BUSINESS PHONE: 86 22-82137264
MAIL ADDRESS:
STREET 1: NO. 6, YUANQUAN ROAD,
STREET 2: WUQING NEW-TECH INDUSTRIAL PARK
CITY: TIANJIN, P.R.
STATE: F4
ZIP: 301700
FORMER COMPANY:
FORMER CONFORMED NAME: STRATEGIKA INC
DATE OF NAME CHANGE: 20020305
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE Amex
CENTRAL INDEX KEY: 0001143313
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 20 BROAD STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5024
MAIL ADDRESS:
STREET 1: 20 BROAD STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN STOCK EXCHANGE LLC
DATE OF NAME CHANGE: 20010620
25-NSE
1
primary_doc.xml
X0203
0001143313
NYSE Amex
0001168556
TIENS BIOTECH GROUP USA INC
001-32477
NO. 6, YUANQUAN ROAD
WUQING NEW-TECH INDUSTRIAL PARK
TIANJIN
F4
CHINA
301700
86 22-82137264
Common Stock, $.001 par value
17 CFR 240.12d2-2(a)(3)
Silvio Conte
Director
2011-08-16
EX-99.25
2
tbv.txt
NOTIFICATION OF THE REMOVAL FROM LISTING AND
REGISTRATION OF THE STATED SECURITIES
NYSE Amex hereby notifies
the SEC of its intention to remove
the entire class of the stated securities
from listing and registration on the
Exchange at the opening of business on
August 29, 2011, pursuant to the provisions
of Rule 12d2-2 (a) 17CFR240.12d2-2(a)(3)
The removal of Tiens Biotech Group (USA),
Inc., Common Stock, $.001 value is
being effected because
the Exchange knows or is reliably
informed that on August 11, 2011 the
instruments representing the
securities comprising the entire
class of this security came to
evidence, by operation of law or
otherwise, other securities in
substitution therefore and
represent no other right except,
if such be the fact, the right
to receive an immediate cash payment.
The security was suspended by the
Exchange on August 12, 2011.